1: Zafon C, Obiols G, Castellvi J, Tallada N, Galofre P, Gemar E, Mesa J, Simo R. Related Articles, Links
nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
J Clin Endocrinol Metab. 2001 Aug;86(8):3975-80.
PMID: 11502841 [PubMed - indexed for MEDLINE]
2: Stravodimos K, Constantinides C, Manousakas T, Pavlaki C, Pantazopoulos D, Giannopoulos A, Dimopoulos C. Related Articles, Links
Immunohistochemical expression of transforming growth factor beta 1 and nm-23 H1 antioncogene in prostate cancer: divergent correlation with clinicopathological parameters.
Anticancer Res. 2000 Sep-Oct;20(5C):3823-8.
PMID: 11268461 [PubMed - indexed for MEDLINE]
3: Hughes KS, Lee AK, Rolfs A. Related Articles, Links
Controversies in the treatment of ductal carcinoma in situ.
Surg Clin North Am. 1996 Apr;76(2):243-65. Review.
PMID: 8610262 [PubMed - indexed for MEDLINE]
4: Quesnel NM, Simonet P. Related Articles, Links
Spectral transmittance of UV-absorbing soft and rigid gas permeable contact lenses.
Optom Vis Sci. 1995 Jan;72(1):2-10.
PMID: 7731651 [PubMed - indexed for MEDLINE]
5: Ueda T, Kamiya K, Urasaki Y, Wataya S, Kawai Y, Tsutani H, Sugiyama M, Nakamura T. Related Articles, Links
Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
Cancer Res. 1994 Jan 1;54(1):109-13.
PMID: 8261429 [PubMed - indexed for MEDLINE]
Time used: 47 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005